Physiological Effects of Resistant Starches on Fecal Bulk, Short Chain Fatty Acids, Blood Lipids and Glycemic Index
David J.A. Jenkins, MD, FACN,
Vladimir Vuksan, PhD,
Cyril W.C. Kendall, PhD,
Pierre Würsch, PhD,
Roger Jeffcoat, PhD,
Susan Waring, BSc,
Christine C. Mehling, RD,
Edward Vidgen, BSc,
Livia S.A. Augustin, MSc and
Evelyn Wong, MSc
Department of Nutritional Sciences (D.J.A.J., V.V., C.W.C.K., C.C.M., E.V., L.S.A.A., E.W.), Faculty of Medicine, University of Toronto and the Clinical Nutrition and Risk Factor Modification Center, St Michaels Hospital, Toronto, Ontario
Nestle Research Center (P.W.), Lausanne, Switzerland
National Starch and Chemical Company (R.J., S.W.), Bridgewater, New Jersey

View larger version (45K):
[in a new window]
|
Fig. 1. Percentage differences in fecal bulk from the low-fiber control for the wheat bran, RS2 and RS3 supplements in 24 subjects.
|
|

View larger version (45K):
[in a new window]
|
Fig. 2. Percentage differences in fecal butyrate concentrations from the low-fiber control for the wheat bran, RS2 and RS3 supplements in 24 subjects.
|
|

View larger version (22K):
[in a new window]
|
Fig. 3. Glycemic indices (mean±SE of cereal supplements (upper panel) and muffin supplements (lower panel) tested in 10 and 11 subjects, respectively. The glycemic index of the wheat bran cereal is significantly lower than that of the low-fiber control cereal (p=0.030).
|
|
Copyright © 1998 by the American College of Nutrition.